Prolactin-secreting pituitary carcinoma with dural metastasis: diagnosis, treatment, and future directions

J Seltzer, JD Carmichael, D Commins, CSJ Liu… - World neurosurgery, 2016 - Elsevier
Background Pituitary carcinoma is extremely rare, representing approximately 0.2% of all
surgically resected pituitary neoplasms. It is thought to arise from World Health Organization …

Management of aggressive pituitary adenomas: current treatment strategies

M Buchfelder - Pituitary, 2009 - Springer
Aggressive pituitary adenomas are notoriously difficult to manage due to their size,
invasiveness, speed of growth and high frequency of recurrence. Except for prolactinomas …

Pituitary carcinoma: a review of the literature

BT Ragel, WT Couldwell - Neurosurgical focus, 2004 - thejns.org
Pituitary carcinomas, defined as distant metastases of a pituitary neoplasm, are rare; fewer
than 140 reports exist in the English literature. The initial presenting pituitary tumor is usually …

Current management of prolactinomas

P Nomikos, M Buchfelder, R Fahlbusch - Journal of neuro-oncology, 2001 - Springer
Prolactinomas constitute the largest group of pituitary adenomas in autopsy series.
However, their relative incidence in recent surgical series is much less impressive since …

Pituitary carcinoma: diagnosis and treatment

MBS Lopes, BW Scheithauer, D Schiff - Endocrine, 2005 - Springer
Pituitary carcinomas are rare pituitary tumors that by definition have cerebrospinal and/or
systemic metastases. Most of the tumors occur in the setting of multiple recurrences of …

Prolactin secreting pituitary adenomas: analysis of 429 surgically treated patients, effect of adjuvant treatment modalities and review of the literature

T Ozgen, HH Oruckaptan, OE Ozcan, B Acıkgoz - Acta neurochirurgica, 1999 - Springer
Summary¶ Objective. We performed this retrospective analysis to determine the efficacy of
surgery and radiotherapy over hormonal and volumetric control of prolactinomas, many of …

Pituitary carcinoma: a clinicopathologic study of 15 cases

PJ Pernicone, BW Scheithauer, TJ Sebo, KT Kovacs… - Cancer, 1997 - Wiley Online Library
BACKGROUND Pituitary carcinomas are rare adenohypophysial neoplasms, the definition,
diagnosis, therapy, and prognosis of which are controversial. METHODS Pituitary …

Prolactin-producing pituitary tumor: resistance to dopamine agonist therapy: case report

K Kovacs, L Stefaneanu, E Horvath, M Buchfelder… - Journal of …, 1995 - thejns.org
✓ A 14-year-old girl presented with a rapidly growing, invasive prolactin-producing pituitary
tumor that failed to respond to dopamine agonist medication. Histological …

Pathobiology of pituitary adenomas and carcinomas

BW Scheithauer, TA Gaffey, RV Lloyd, TJ Sebo… - …, 2006 - journals.lww.com
OBJECTIVE: To examine relationships between pituitary tumors and lesion size,
invasiveness, resectability, deoxyribonucleic acid ploidy, cell cycle profile, mitotic activity …

A prognostic clinicopathologic classification of pituitary endocrine tumors

G Raverot, A Vasiljevic, E Jouanneau… - Endocrinology and …, 2015 - endo.theclinics.com
Endocrine pituitary tumors arise from adenohypophyseal cells. Their classification has
evolved over the years supported by continuing improvements of numerous technologies …